Shares of Waters rose 8.8 percent for the five-day trading period ended Tuesday to lead all stocks in the BCW Index. Its shares rose nearly 9 percent on Tuesday alone after the firm reported 17 percent revenue growth for its third quarter.
 
Caliper Life Sciences and Agilent Technologies led decliners for the tracking period, falling 2.8 percent and 2.5 percent, respectively.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.